These findings have raised the question as to whether increased fetuin-A levels can predict development of findings of metabolic syndrome, such as insulin resistance, hyperlipidemia, NAFLD and increased CIMT values are added over time, in T1DM patients with poor glycemic control. This evidence concerns the gene AHSG and metabolic syndrome.